CCMH
CADX

Cornerstone Capital Management Holdings’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-93,600
Closed -$846K – 1473
2013
Q4 		$846K Buy
93,600
+49,900
+114% +$360K 0.01% 855
2013
Q3 		$275K Buy
+43,700
New +$278K ﹤0.01% 1006

Other funds holding CADX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Cornerstone Capital Management Holdings's CADX Position: Q1 2014 in Review

Cornerstone Capital Management Holdings sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 93,600 shares — an estimated $846K sold.

Cornerstone Capital Management Holdings first reported a position in CADX in Q3 2013 and held it in 2 quarters. The position peaked at $846K in Q4 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

  • Cornerstone Capital Management Holdings reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 93,600 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $846K.
  • Cornerstone Capital Management Holdings first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q3 2013 and held it in 2 quarters.
  • Cornerstone Capital Management Holdings's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $846K in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on Cornerstone Capital Management Holdings's 13F filing for Q1 2014, filed 15 May 2014.